|Day Low/High||68.79 / 70.47|
|52 Wk Low/High||54.33 / 74.92|
We updated two price targets and downgraded the rating on another position.
Jim Cramer weighs in on Abbott, GlaxoSmithKline, Waste Management and more.
Investors are stressing about the economy and the Fed, which has little room to maneuver, Jim Cramer says.
Market sentiment has certainly improved from this weekend's events.
The market responded favorably after Fed Chair Jerome Powell portrayed a more dovish stance on interest rates.
Jim discusses Palo Alto Networks' earnings from Thursday night, why we remain bullish on Amazon and Salesforce.com, and much more!
Jim Cramer looks for stocks that have potential, especially if trade and tariff woes out of the G-20 meeting stir up volatility.
Jim Cramer takes a look at DowDuPont, AT&T, Home Depot, New York Mortgage Trust, Nio, Abbott Laboratories, Nielsen and more.
We are in the process of reviewing the portfolio, addressing what positions need to be altered as we approach the end of the year.
VANCOUVER, Nov. 22, 2018 /CNW/ - Absolute® (TSX:ABT) (the " Company"), the end point visibility and control company, announced today that one of its largest shareholders has agreed to support the Company's nominees for directors being Salvatore Visca,...
Jim Cramer recommends that consumers use these stocks to buy the stocks that have been beaten down by the looming bear market.
Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.
- Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful
Here's why October was a dream for investors.
ABBOTT PARK, Ill., Nov.
Markets had another volatile week as trade tensions crossed currents with a U.S. midterm election that was closer than many had predicted.
We think defense stocks, among other sectors, can rally.
Stephen 'Sarge' Guilfoyle gives you a rundown of what's in his portfolio as the new month gets rolling.
In light of recent market volatility, we want club members to know our view on every stock we own.
A lot of names now suddenly present as dividend plays that maybe we do not think of in that way.
NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT
It becomes difficult for me to tell you where to run in these markets...
This earnings season could be full of surprises. Jim Cramer has your game plan for next week.
Jim Cramer says there's still too much greed and complacency, and not enough fear and panic.
Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.
Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.